Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer - Maguire, P; Papagikos, M; Hamann, S; Neal, C; Meyerson, M; Hayes, N (Int J Radiat Oncol Biol Phys, 2011)
et al.